tiprankstipranks
Merck (NYSE:MRK) and Big Pharma Face Down Wave of Generics in 2025
PremiumMarket NewsMerck (NYSE:MRK) and Big Pharma Face Down Wave of Generics in 2025
6d ago
Bristol Myers CEO says new drug Cobenfy effective in schizophrenia, CNBC reports
Premium
The Fly
Bristol Myers CEO says new drug Cobenfy effective in schizophrenia, CNBC reports
7d ago
Drugmakers to push Trump to pause price negotiations, Bloomberg reports
Premium
The Fly
Drugmakers to push Trump to pause price negotiations, Bloomberg reports
7d ago
Bristol Myers Squibb call volume above normal and directionally bullish
PremiumThe FlyBristol Myers Squibb call volume above normal and directionally bullish
19d ago
PFE, BMY, SNY, and Others Are Set to Raise Prices on 250 Drugs
Premium
Market News
PFE, BMY, SNY, and Others Are Set to Raise Prices on 250 Drugs
21d ago
Bristol-Myers Squibb’s Patent Expansion Plan May Run into Regulator Trouble
Premium
Market News
Bristol-Myers Squibb’s Patent Expansion Plan May Run into Regulator Trouble
22d ago
Bristol Myers announces ‘positive’ results from Phase 3 Sotyktu trials
PremiumThe FlyBristol Myers announces ‘positive’ results from Phase 3 Sotyktu trials
29d ago
Bristol Myers receives EC approval for Opdivo plus Yervoy
Premium
The Fly
Bristol Myers receives EC approval for Opdivo plus Yervoy
29d ago
Buy/Sell: Wall Street’s top 10 stock calls this week
Premium
The Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100